| |
| |
|
| Insider
Information: |
Bennett C Frank |
| Relationship: |
Officer Level 14 |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
79,462 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,985,387 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
79,462 |
|
|
| Total
Value |
$2,985,387 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -99.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Officer Level 14 |
2024-02-29 |
79,462 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-12-16 |
4 |
AS |
$58.85 |
$230,045 |
D/D |
(3,909) |
7,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-12-16 |
4 |
OE |
$14.47 |
$56,563 |
D/D |
3,909 |
11,225 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,984 |
7,943 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-12-15 |
4 |
AS |
$56.00 |
$224,000 |
D/D |
(4,000) |
7,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-12-15 |
4 |
OE |
$14.47 |
$57,880 |
D/D |
4,000 |
11,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-01-15 |
4 |
D |
$62.06 |
$258,294 |
D/D |
(4,162) |
32,195 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-09-28 |
4 |
AS |
$46.50 |
$207,390 |
D/D |
(4,460) |
65,754 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2007-07-09 |
4 |
OE |
$5.15 |
$23,685 |
D/D |
4,599 |
5,929 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-12-29 |
4 |
OE |
$9.63 |
$44,275 |
D/D |
4,600 |
5,161 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2010-12-29 |
4 |
AS |
$10.32 |
$47,449 |
D/D |
(4,600) |
561 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-08-27 |
4 |
OE |
$15.38 |
$76,900 |
D/D |
5,000 |
6,627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-08-27 |
4 |
AS |
$40.50 |
$202,630 |
D/D |
(5,000) |
4,627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-11-06 |
4 |
OE |
$14.47 |
$72,350 |
D/D |
5,000 |
12,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-11-06 |
4 |
AS |
$56.00 |
$280,000 |
D/D |
(5,000) |
7,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-11-10 |
4 |
AS |
$64.00 |
$320,000 |
D/D |
(5,000) |
7,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-11-10 |
4 |
OE |
$14.47 |
$72,350 |
D/D |
5,000 |
12,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2016-11-07 |
4 |
OE |
$11.27 |
$56,350 |
D/D |
5,000 |
15,803 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2016-11-07 |
4 |
AS |
$34.00 |
$170,000 |
D/D |
(5,000) |
10,803 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2017-03-03 |
4 |
AS |
$55.00 |
$275,000 |
D/D |
(5,000) |
14,788 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2017-03-03 |
4 |
OE |
$10.29 |
$51,450 |
D/D |
5,000 |
19,788 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2016-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,295 |
11,112 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-01-15 |
4 |
D |
$61.28 |
$336,305 |
D/D |
(5,488) |
42,508 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2007-07-09 |
4 |
AS |
$10.57 |
$61,073 |
D/D |
(5,732) |
197 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2008-08-20 |
4 |
OE |
$6.81 |
$40,860 |
D/D |
6,000 |
6,537 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2008-08-20 |
4 |
AS |
$17.97 |
$107,820 |
D/D |
(6,000) |
537 |
0 |
- |
|
191 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
